Ipamorelin
Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue (GHS) that stimulates pituitary GH release through targeted ghrelin receptor activation without affecting other hormones.
Ipamorelin binds to the ghrelin receptor (GHS-R1a), mimicking natural ghrelin action while exhibiting unique selectivity that avoids cortisol, prolactin, or ACTH elevation seen with other secretagogues like GHRP-6.
Research demonstrates Ipamorelin's controlled GH secretion without overstimulation, increasing IGF-1 levels and improving bone density markers while avoiding appetite stimulation typical of ghrelin mimetics.
Studies confirm sustained effectiveness without receptor desensitization, making it valuable for research in growth hormone deficiency, muscle mass preservation, and age-related metabolic decline.
Ipamorelin provides selective GH stimulation, preserved hormonal balance, and controlled pulsatile release, offering researchers a clean tool for investigating growth hormone regulation without confounding endocrine variables.
Composition: Ipamorelin (5 mg)